Legal Opinion
Erfindergemeinschaft UroPep GbR v. Lilly
District Court, E.D. Texas
Decided August 25, 2017No. Case No. 2:15-CV-1202-WCBPublishedCited by 21 opinions
1Opinion of the Court
MEMORANDUM OPINION AND ORDER
WILLIAM C. BRYSON, UNITED STATES CIRCUIT JUDGE
In this patent infringement case, the plaintiff Erfindergemeinschaft UroPep GbR (“UroPep”), a German association of urology researchers and physicians, sued the defendant Eli Lilly and Company (“Lilly”) for infringement of U.S. Patent No. 8,791,124 (“the ’124 patent”). Claim 1 of the 124 patent is to a method of administering an effective amount of a compound known as an inhibitor of the enzyme phos-phodiesterase (“PDE”) V, in order to treat the condition of benign prostatic hyperpla-sia (“BPH”). UroPep alleged that…
2Cases cited73 opinions
- Mayo Collaborative Services v. Prometheus Laboratories, Inc.Supreme Court of the United States · 2012
- Nautilus, Inc. v. Biosig Instruments, Inc.Supreme Court of the United States · 2014
- Bilski v. KapposSupreme Court of the United States · 2010
- Laxton v. Gap Inc.Court of Appeals for the Fifth Circuit · 2003
- Diamond v. DiehrSupreme Court of the United States · 1981
68 more not listed; retrieve them via the Exa API.
3Cited by21 opinions
- Juno Therapeutics, Inc. v. Kite Pharma, Inc.Court of Appeals for the Federal Circuit · 2021
- In re Biogen 755 Patent Litig.District Court, D. New Jersey · 2018
- Novartis Pharmaceuticals v. Accord Healthcare Inc.Court of Appeals for the Federal Circuit · 2022
- Pernix Ir. Pain Dac v. Alvogen Malta Operations Ltd.District Court, D. Delaware · 2018
- Alfonso Cioffi v. Google, LLCDistrict Court, E.D. Texas · 2021
16 more not listed; retrieve them via the Exa API.